Other Income/Expenses (Net)

$1.20B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$1.20Bperiod endingJun 30, 2026

REGN TTM Other Income/Expenses (Net) ($0.00 → $1.20B)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

REGN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	57,793,000
Mar 31, 2001	43,590,000
Dec 31, 2000	37,359,000
Sep 30, 2000	28,549,000
Jun 30, 2000	13,262,000
Mar 31, 2000	17,780,000
Dec 31, 1999	19,700,000
Sep 30, 1999	19,700,000
Jun 30, 1999	21,900,000
Mar 31, 1999	12,800,000
Dec 31, 1998	3,500,000
Sep 30, 1998	1,600,000
Jun 30, 1998	300,000
Mar 31, 1998	4,700,000
Dec 31, 1997	7,700,000
Sep 30, 1997	8,900,000
Jun 30, 1997	12,200,000
Mar 31, 1997	12,200,000
Dec 31, 1996	12,800,000
Sep 30, 1996	15,500,000
Jun 30, 1996	13,500,000
Mar 31, 1996	11,100,000
Dec 31, 1995	7,600,000
Sep 30, 1995	10,000,000
Jun 30, 1995	11,300,000
Mar 31, 1995	20,000,000
Dec 31, 1994	29,200,000
Sep 30, 1994	35,300,000
Jun 30, 1994	40,900,000
Mar 31, 1994	40,700,000
Dec 31, 1993	39,500,000
Sep 30, 1993	34,400,000
Jun 30, 1993	30,700,000
Mar 31, 1993	24,400,000
Dec 31, 1992	18,400,000
Sep 30, 1992	13,900,000
Jun 30, 1992	8,300,000
Mar 31, 1992	4,800,000
Dec 31, 1991	1,600,000
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0